QUARTERLY RESULTS
FINANCIAL RESULTS  FOR THE QUARTER AND NINE MONTHS  ENDED   31st DECEMBER 2011
(Rs. In lacs.)
PARTICULARS QUARTER ENDED   NINE MONTHS ENDED YEAR ENDED
  (UNAUDITED) (UNAUDITED) (AUDITED)
  31.12.11 30.09.11 31.12.10 31.12.11 31.12.10 31.03.11
             
INCOME FROM OPERATIONS 28837.37 24315.89 24607.61 77196.52 63941.31 87815.28
OTHER OPERATING INCOME 0.00 155.31 0.00 1520.12 14.99 1600.74
TOTAL INCOME FROM OPERATIONS 28837.37 24471.20 24607.61 78716.64 63956.30 89416.02
EXPENDITURE            
INC.(-)/DEC.(+)IN STOCK AND W.I.P. -4331.13 -3246.99 -4002.53 -12287.62 -8998.76 -11092.57
CONSUMPTION OF RAW MATERIAL 26211.06 21387.37 23348.73 71113.28 57963.34 78479.29
EMPLOYEES COST 1133.12 953.88 578.69 2804.58 1807.25 2612.58
DEPRECIATION / AMORTISATION 454.82 404.84 386.36 1299.77 1156.36 1551.38
OTHER EXPENDITURE 2794.97 2215.79 1945.11 7193.74 5240.94 8032.56
TOTAL EXPENDITURE 26262.84 21714.89 22256.36 70123.75 57169.13 79583.24
PROFIT FROM OPERATIONS 2574.53 2756.31 2351.25 8592.89 6787.17 9832.78
OTHER INCOME 189.04 112.39 141.58 321.25 270.74 463.26
PROFIT BEFORE INTEREST 2763.57 2868.70 2492.83 8914.14 7057.91 10296.04
INTEREST 1590.81 1751.51 1459.37 5039.85 3891.25 5815.16
PROFIT BEFORE TAX 1172.76 1117.19 1033.46 3874.29 3166.66 4480.88
PROVISION FOR TAX 234.67 223.55 205.97 775.25 631.12 879.83
MAT CREDIT ENTITELMENT (234.67) (223.55) (205.97) (775.25) (631.12) (879.83)
PROVISION FOR DEFFERED TAX 25.00 25.00 25.00 100.00 100.00 147.21
ADD INCOME TAX PREVIOUS YEAR ADJ. 0.00 0.00 0.00 0.00 0.00 11.50
NET PROFIT 1147.76 1092.19 1008.46 3774.29 3066.66 4345.17
SHARE CAPITAL 843.57 843.57 782.69 843.57 782.69 843.57
BASIC EARNING PER SHARE 2.72 2.59 2.59 8.95 7.87 11.13
DILUTED EARNING PER SHARE 2.33 2.22 2.46 7.67 7.48 10.87
NOMINAL VALUE PER SHARE 2.00 2.00 2.00 2.00 2.00 2.00
Public Shareholding            
No. of Shares 28790064 28790064 22790064 28790064 22790064 28790064
% of shareholding 56.40 56.40 58.23 56.40 58.23 56.40
Promoters & Promoters group Shareholding             
a) Pledged/ encumberered Nil Nil nil Nil nil Nil
     - No. of Shares Nil Nil nil Nil nil Nil
     -% of shares (as a % of the total shareholding of             
      promoter & promoter group Nil Nil nil Nil nil Nil
  - % of shares( as a % of the total share capital of the             
    company Nil Nil nil Nil nil Nil
b) Non- Encumbered            
     - No. of Shares 18388306 18388306 16344306 18388306 16344306 18388306
     -% of shares (as a % of the total shareholding of             
      promoter & promoter group 100 100 100 100 100 100
  - % of shares( as a % of the total share capital of the             
    company 43.60 43.60 41.77 43.60 41.77 43.60
Notes:-
1. During the quarter under review, the income from operations has grown by 17% and profit from operations has shown an increase of 13% as compared to same period during previous year.
2. The company is exclusively in Pharmaceutical segment.
3. Information on the Investors' compalints for the quarter: Opening-Nil, Recived-06, Resolved-06, pending-Nil
4. Previous period figures have been re-grouped/ re-arranged wherever necessary
5. The abovesaid results were taken into record by the Audit committee and Board of Directors of the company in    their respective meetings held on 8th February 2012
On behalf of Board of Directors
Place:Chandigarh (S.R.Mehta)
Date: 08.02.2012 Chairman